Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Sivas
Clinical trial register · Turkey

Clinical Trials in Sivas, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5436 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5436
Studies in scope
all four open statuses
2491
Recruiting now
open to new participants
546
Lead sponsors
across recruiting studies
Top sites
Istanbul 19 Ankara 9 Adana 8 Antalya 6 Kayseri 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novo Nordisk A/S2 Cumhuriyet University1
Site location
Istanbul19 Ankara9 Adana8 Antalya6 Kayseri5 Denizli4 Yuregir/Adana4 Afyonkarahisar4 Bursa4 Merkez/Battalgazi/Malatya3 Yıldırım/Bursa3 Eskişehir3 Kocaeli3 Sivas3 Alanya/ Antalya2 Maltepe/İstanbull2 Merkez/Çorum2 Yenimahalle / Ankara2 Zeytinburnu/İstanbul2 Izmir2 Diyarbakır2 Bahçelievler/İstanbul2 Çankaya/Ankara2 Gaziantep2 Çorum1 Show all 51
All 51 locations
Target enrolment
to

Trials with a site in Sivas

3 of 5436 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Cumhuriyet University
Not applicable
52
Sivas
2026-12-15
Active, closed
Novo Nordisk A/S
Phase 3
985
Adana /yüreği̇r, Ankara, Battalgazi / Malatya, Istanbul, Pendik/istanbul, Sivas, Yüreğir/Adana
2026-05-20
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Ankara, Sultangazi, Adana, Antalya, Hatay, Istanbul, Sivas
2022-11-01
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-turkey/city/sivas

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,436 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Sivas that also match the filters currently applied.

How many clinical trials are recruiting in Sivas?

0 of the 3 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sivas), 3 studies
PhaseStudiesRecruitingShare
Phase 32066.7%
Not applicable1033.3%

Most active sponsors

Lead sponsors with the most studies (Sivas)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S20
Cumhuriyet University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.